Want to see PLUR full AI Analyst Report?
Compare Pluri (PLUR) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| PLURPluri | $1.24 | $15.64M | -0.51 | -68.12% | ― | Unlock the PLUR analyst price target with TipRanks Premium | PLUR | Unlock the PLUR top-analyst price target with TipRanks Premium | ||
| IGCIGC Pharma | $0.19 | $21.49M | -2.25 | -53.63% | Moderate Buy | Unlock the IGC analyst price target with TipRanks Premium | PLUR vs IGC | Unlock the IGC top-analyst price target with TipRanks Premium | ||
| PYPDPolyPid | $5.39 | $109.48M | -3.64 | 40.36% | Strong Buy | Unlock the PYPD analyst price target with TipRanks Premium | PLUR vs PYPD | Unlock the PYPD top-analyst price target with TipRanks Premium | ||
| ANTXAN2 Therapeutics, Inc. | $4.53 | $170.95M | -4.23 | 265.32% | ― | Unlock the ANTX analyst price target with TipRanks Premium | PLUR vs ANTX | Unlock the ANTX top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PLUR | Pluri | 1.24 | -2.45 | -66.40% | |
| IGC | IGC Pharma | 0.18 | -0.22 | -53.98% | |
| PYPD | PolyPid | 5.39 | 1.60 | 42.22% | |
| ANTX | AN2 Therapeutics, Inc. | 4.53 | 3.38 | 293.91% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
